Date: February 12-13, 2021
Location: Four Seasons – Austin, Texas
Cost: $595 General; $395 Military; $50 Resident
Description: Join us for a two-day event in Austin, Texas to hear experts in regenerative medicine discuss, Regenerative Solutions to Common Problems
You have been referred a 65 female on a bisphosphonate for an extraction and immediate dental implant on #19. What is the best way to proceed? The patient wants to know her risk of medication related osteonecrosis of the jaws (MRONJ) and what you will do to reduce it? This comprehensive overview of MRONJ will cover this and more. It will review medications that cause MRONJ and which ones are more problematic, along with the frequency and risk of disease. It will review risk and prevention strategies. The staging and current management including the latest research, clinical trials and future treatment therapies will also be reviewed.
Jasjit Kaur Dillon is an Associate Clinical Professor and Program Director of Oral and Maxillofacial Surgery at the University of Washington, Seattle. She obtained her dental degrees from the University of Newcastle Upon Tyne (BDS), the University of California San Francisco (DDS) and her medical degree from St Bartholomew’s School of Medicine, University of London (MBBS). She is a member of the Royal College of Surgeons of England (FDSCRCS), the American College of Surgeons (FACS) and is an examiner for the American Board of OMFS. She has numerous peer reviewed scientific publications, book chapters, lectures nationally and internationally and is the principle investigator on a multi-centered clinical trial on medication related osteonecrosis of the jaw.
Bone Graft Complications
Failures and complications associated with bone augmentation can have a devastating effect on the outcome of dental implant treatment. These complications are classified as either early or late. Early complications include wound dehiscence, membrane and graft exposure, and infection, with the most common complication being wound dehiscence. Late complications of bone augmentation are now recognized more frequently and include late resorption, foreign body reaction, late breakdown of grafted sites, lack of keratinized tissue and poor esthetics, as well as implant failure. This clinical presentation will focus on how to identify and avoid potential complications before they arise and how to manage many of the common complications that can occur with bone augmentation procedures. Emphasis will be given to risk assessment, classifications of complications and treatment of challenging failures.
Dr. Bach Le completed his specialty training in Oral & Maxillofacial Surgery at Oregon Health Sciences University. He is currently Clinical Associate Professor of Oral & Maxillofacial Surgery at the USC School of Dentistry. Dr. Le maintains a private practice in Whittier, California. Dr. Le has lectured both nationally and internationally on bone regeneration and dental implant-related surgery and has published extensively in scientific texts and professional journals. Dr. Le is a Diplomate of the American Association of Oral & Maxillofacial Surgeons, the American Dental Society of Anesthesiologist and the International Congress of Oral Implantologists, and holds Fellowship in the International College of Dentists, the American College of Dentists and the International Association of Oral & Maxillofacial Surgeons.
Practical Access to Stem Cells for Oral and Maxillofacial Bone Regeneration
Robert E. Marx, DDS, is Professor of Surgery and Chief of the Division of Oral and Maxillofacial Surgery at the University of Miami Miller School of Medicine as well as Chief of Surgery at Jackson South Community Hospital in Miami, He is well known as an educator, researcher, and innovative surgeon. He has pioneered new concepts and treatments for pathologies of the oral and maxillofacial area as well as new techniques in reconstructive surgery including stem cell therapies.
His many prestigious awards, including the Harry S. Archer Award, the William J. Giles Award, the Paul Bert Award, the Donald B. Osbon Award, and the Daniel Laskin Award, attest to his accomplishments and commitment to the field of oral and maxillofacial surgery.
His textbook “Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment” has also won the American Medical Writers Associations Prestigious Book of the year Award and his other textbooks “Platelet Rich Plasma: Dental and Craniofacial Applications”, “Tissue Engineering”, “Oral and Intravenous Bisphosphonates Induced Osteonecrosis”, and an “Atlas of Bone Harvesting” have been best sellers. He is also a writer of fiction medical mystery novels. His first publication “Deadly Prescription” is currently a “Best Seller” on Amazon.
Soft Tissue Substitutes
“Evidence-Based Alternatives to Autogenous Tissue: Outcomes – Phenotype – Stability”
Our goal in soft tissue reconstruction is to maximize clinical outcomes while reducing morbidity. New devices are being introduced that may be able to achieve these goals. This program will explore autogenous tissue alternatives along with evidence-based decision trees on when alternatives should be considered and how to improve outcomes.
Upon completion of this presentation, participants should be able to:
Dr. McGuire is the primary author of over fifty scientific articles and textbook chapters, an unparalleled achievement for someone in full time private practice. He serves on the editorial board of multiple publications and is the founder and chairman of the McGuire Institute, a not-for-profit practice-based clinical research network.
An eminent speaker, having given over 200 continuing education programs, Dr. McGuire has lectured for both national and international audiences. His research has received the American Academy of Periodontology’s highest recognition for excellence, four times earning the Robinson Regeneration Award and twice the Clinical Research Award. He is also the recipient of the Academy’s prestigious Master Clinician Award and the Academy’s highest honor, the Gold Medal Award. In 2015 he received the William J. Gies Periodontology Award for his distinguished achievement in periodontology.
Dr. McGuire is past Chairman of the American Board of Periodontology. He has served as president of numerous dental organizations, including the American Academy of Periodontology and the American Academy of Periodontology Foundation. He is a voting member of the FDA Dental Products Devices Panel. Emory University recognized Dr. McGuire with their Distinguished Alumnus Award in 2009.
Bone Augmentation Update
Craig M. Misch, DDS, MDS graduated from the University of Michigan School of Dentistry. He then received postgraduate certificates in prosthodontics and oral implantology as well as a Master of Dental Science degree from the University of Pittsburgh. Dr. Misch acted as Co-Director of the University of Pittsburgh Oral Implantology Center until he entered specialty training in oral and maxillofacial surgery. He completed this residency in 1999 and is a Diplomate of the American Board of Oral and Maxillofacial Surgery as well as Diplomate of the American Board of Oral Implantology. He currently practices as a dual specialist in Sarasota, Florida. Dr. Misch is a Clinical Associate Professor at New York University in the Department of Implant Dentistry and at the University of Florida in the Departments of Periodontics and Prosthodontics. Dr. Misch is a member of the editorial boards of International Journal of Oral and Maxillofacial Implants, International Journal of Periodontics and Restorative Dentistry, Implant Dentistry and the Journal of Oral Implantology. He has authored over 45 publications including 14 textbook chapters. Dr. Misch lectures extensively on the topics of reconstructive surgery, bone grafting, implant surgery and prosthodontics and has been designated as a “Leader in Continuing Education” by Dentistry Today.
Soft Tissue Grafting Around Dental Implants
Dr. Anthony G. Sclar is widely recognized—both by his patients and his peers—as being one of the world’s leading practitioners of oral surgery and implant dentistry. Throughout his career, Dr. Sclar has gained extensive experience in reconstructive and esthetic dental implant surgery, periodontal plastic surgery and corrective and cosmetic jaw, chin and cheek bone procedures. Since 1989 he has performed more than 15,000 successful dental implant procedures at his private practice in Miami, Florida. His patients originate from South Florida and the Continental U.S., South and Central America, and the Caribbean. They seek out Dr. Sclar not only for his unsurpassed surgical skills for which he gained the nickname “Manos de Seda” (“hands of silk”) but also for his caring and compassionate approach to treatment.
A much sought-after educator and lecturer, Dr. Sclar is the author of numerous publications including the hallmark multi-language textbook, Soft Tissue and Esthetic Considerations in Implant Therapy, (Quintessence 2003). He has made presentations to top dental professionals throughout the USA, Germany, Italy, Spain, France, Switzerland, the UK, Australia, Africa, Taiwan, and Canada.
An accomplished professional, Dr. Sclar is an Adjunct Professor and Director of Clinical Research and Dental Implant Surgery in the Department of Oral and Maxillofacial Surgery, Nova Southeastern University College of Dentistry and is an active contributor to numerous global organizations involved in furthering research and education in the field of implant dentistry.
An innovator, Dr. Sclar developed numerous surgical procedures that led to advancements in esthetic and reconstructive implant dentistry resulting in improved outcomes, greater predictability and less discomfort and down time for patients undergoing dental implant and oral surgery procedures.
Due to state restrictions, residents who are not already licensed in Florida will not be able to obtain a dental license for this program. If the resident has an MD degree, however, it would be possible to obtain a medical license in Florida. Otherwise, the resident can act as first assistant.
“Treatment concepts for the management of Peri-Implantitis”
Previous studies have indicated that surgical treatment of peri-implantitis with concomitant placement of a bone filler is associated with clinical and radiographic improvements on both short- and long-term periods. However, the available evidence also suggests, that the effectiveness of regenerative treatment approaches is influenced by several factors, such as the type and configuration of the defect, implant surface characteristics, as well as the method of surface decontamination.
Frank Schwarz is Professor and Chairman of the Department of Oral Surgery and Implantology at the Centre for Dentistry and Oral Medicine (Carolinum), Johann Wolfgang Goethe-University Frankfurt, Germany. He serves as an Associate Editor for the Journal of Clinical Periodontology and Editorial Board Member for Clinical Oral Implants Research. He is past President of the German Association of Oral Implantology (DGI), Executive Board Member of the Osteology Foundation and was awarded the André Schröder Research Prize in 2007, the Miller Research Prize in 2012 and the Jan Lindhe Award in 2017.
Sinus Grafting 30 Years: Myths and Realities
Sinus Grafting 30 Years: Myths and Realities
This clinical based presentation is based on the presenter’s 30-year experience with sinus grafting. It will focus on myths and realities of selection criteria and biology of graft materials, physiology of the sinus membrane, management of large and complete membrane perforations, grafting in the presence of pathology, and management of sinus graft infections along with management of complications of both lateral and crestal sinus grafts.
Dr. Michel A. Pikos, Oral Maxillofacial Surgeon, graduated Summa Cum Laude and Phi Beta Kappa from The Ohio State University. He is founder and CEO of the Pikos Institute. Since 1990, he has been teaching advanced bone and soft tissue grafting courses along with full arch immediate reconstruction courses with alumni that now number more than 4300 from all 50 states and 43 countries. He has lectured extensively on dental implants in the U.S. and internationally and is a well published author including his recent book “Bone Augmentation in Implant Dentistry.” Dr. Pikos maintains a private practice which is limited exclusively to implant Reconstruction surgery in Trinity, Florida.
Development of a Compromised Maxillofacial Wound Healing Model for Bone Graft Evaluation
Bone grafting of maxillofacial defects is a predictable procedure in many cases, with surgeon preference typically dictating the use of autogenous, allogeneic or xenogeneic materials alone or in combination. However, the “compromised” wound healing environment remains one of the biggest challenges to maxillofacial bone regeneration today. Examples of such challenging clinical scenarios include bone grafting in the setting of osteoradionecrosis, medication-related osteonecrosis of the jaw and even multiply-operated maxillofacial defects. We will discuss a recently developed pre-clinical model of compromised maxillofacial wound healing and how it can serve as a platform for (1) elucidation of key differences between compromised and non-compromised maxillofacial wound environments in the context of standard bone grafting techniques, and (2) evaluation of personalized bioactive scaffolds in a compromised wound bed.
Dr. Young is a board-certified Oral & Maxillofacial Surgeon with an interest in the treatment and reconstruction of craniomaxillofacial trauma and pathology. He has broad experience in the fields of polymer synthesis, polymer characterization, growth factor delivery, in vivo models and characterization of bone and neovascularization. His research efforts include the synthesis and characterization of implantable materials designed to elicit in situ cell recruitment and programming. One aspect of this work includes the use of materials able to simultaneously deliver multiple growth factors with distinct release profiles, for the promotion of bone regeneration in the craniomaxillofacial complex.
A room block has been made at the Four Seasons Austin, which is the site of the meeting. www.fourseasons.com
Reservations must be made by calling the hotel directly at 512-685-8100. Please reference Osteo Science Foundation in order to receive the discounted rate of $299/night. Rates are subject to applicable sales and occupancy taxes, which are currently 15% but are subject to change. A $4.50 state-cost recovery fee will be added to each room. The cut-off date for the room block is January 15, 2021.*Please note that you will not be extended the discounted rate if you book online.
While a room block has only been made at the Four Seasons, there are budget-conscious hotel options nearby, including the following:
Hyatt Place Austin Downtown
211 E 3rd St, Austin, TX 78701•(512) 476-4440
4-minute drive from the Four Seasons
Aloft Austin Downtown
109 East 7th Street, Austin, Texas 78701 +1 512-476-2222
6-minute drive from the Four Seasons
Hampton Inn & Suites Austin-Downtown/Convention Center
200 San Jacinto Blvd, Austin, TX 78701•(512) 472-1500
5-minute drive from the Four Season
Extended Stay America – Austin -Downtown 6th St.
600 Guadalupe St, Austin, TX 78701•(512) 457-9994
5-minute drive from the Four Seasons
The Austin Bergstrom International Airport is 20 minutes from the Four Seasons; additional hotel options can be found near the airport.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and Osteo Science Foundation. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.
The PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 14 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Osteo Science Foundation
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by any regulatory authority, or AGD endorsement.
7/1/18 to 6/30/21
Provider ID: 370582